Literature DB >> 3156640

Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.

A T Nurden, D Didry, N Kieffer, R P McEver.   

Abstract

Glanzmann's thrombasthenia is an inherited bleeding disorder characterized by abnormalities of platelet membrane glycoproteins (GP) IIb and IIIa. Most patients, usually designated as type I, have been reported to have undetectable levels of GP IIb and GP IIIa with the assay used. We have used polyclonal rabbit antibodies against GP IIb and GP IIIa in a sensitive immunoblot procedure capable of revealing trace amounts of these glycoproteins. Platelets from nine thrombasthenic patients, including seven with type I disease, were studied. GP IIIa, although decreased, was clearly detectable in platelets of eight patients and GP IIb was identified in five. Our findings suggest that residual quantities of GP IIb and GP IIIa are present in most patients with thrombasthenia and therefore that major deletions in the gene or genes encoding these proteins are uncommon.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156640

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets.

Authors:  S L Pfueller; D Logan; T T Tran; R A Bilston
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 2.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

3.  Assignment of human platelet GP2B (GPIIb) gene to chromosome 17, region q21.1-q21.3.

Authors:  N V Cong; G Uzan; M S Gross; C Jegou-Foubert; P Frachet; C Boucheix; G Marguerie; J Frézal
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

4.  The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.

Authors:  P J Newman; U Seligsohn; S Lyman; B S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 5.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.

Authors:  C D Burk; P J Newman; S Lyman; J Gill; B S Coller; M Poncz
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.

Authors:  N Kieffer; L A Fitzgerald; D Wolf; D A Cheresh; D R Phillips
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

8.  Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia.

Authors:  Thomas A Blair; Alan D Michelson; Andrew L Frelinger
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

9.  Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.

Authors:  Michel Laguerre; Essa Sabi; Martina Daly; Jacqueline Stockley; Paquita Nurden; Xavier Pillois; Alan T Nurden
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.